nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—type 2 diabetes mellitus	0.26	0.718	CbGaD
Bicalutamide—CYP3A4—type 2 diabetes mellitus	0.102	0.282	CbGaD
Bicalutamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0232	0.0521	CbGbCtD
Bicalutamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0227	0.051	CbGbCtD
Bicalutamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0207	0.0466	CbGbCtD
Bicalutamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0197	0.0443	CbGbCtD
Bicalutamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0197	0.0443	CbGbCtD
Bicalutamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0193	0.0433	CbGbCtD
Bicalutamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0182	0.0409	CbGbCtD
Bicalutamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0176	0.0395	CbGbCtD
Bicalutamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0164	0.0369	CbGbCtD
Bicalutamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0164	0.0369	CbGbCtD
Bicalutamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0151	0.034	CbGbCtD
Bicalutamide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.015	0.0337	CbGbCtD
Bicalutamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0148	0.0333	CbGbCtD
Bicalutamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0146	0.0328	CbGbCtD
Bicalutamide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0138	0.0311	CbGbCtD
Bicalutamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0134	0.03	CbGbCtD
Bicalutamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0132	0.0296	CbGbCtD
Bicalutamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0124	0.0279	CbGbCtD
Bicalutamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0121	0.0271	CbGbCtD
Bicalutamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0119	0.0268	CbGbCtD
Bicalutamide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0114	0.0255	CbGbCtD
Bicalutamide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0109	0.0245	CbGbCtD
Bicalutamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0105	0.0237	CbGbCtD
Bicalutamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0101	0.0227	CbGbCtD
Bicalutamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00953	0.0214	CbGbCtD
Bicalutamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00923	0.0208	CbGbCtD
Bicalutamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00839	0.0189	CbGbCtD
Bicalutamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00767	0.0173	CbGbCtD
Bicalutamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00722	0.0162	CbGbCtD
Bicalutamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00692	0.0156	CbGbCtD
Bicalutamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00692	0.0156	CbGbCtD
Bicalutamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00655	0.0147	CbGbCtD
Bicalutamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00488	0.011	CbGbCtD
Bicalutamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00446	0.01	CbGbCtD
Bicalutamide—Enzalutamide—AR—type 2 diabetes mellitus	0.00152	0.576	CrCbGaD
Bicalutamide—Enzalutamide—CYP3A4—type 2 diabetes mellitus	0.000596	0.226	CrCbGaD
Bicalutamide—Enzalutamide—ALB—type 2 diabetes mellitus	0.00052	0.198	CrCbGaD
Bicalutamide—Constipation—Gliclazide—type 2 diabetes mellitus	7.55e-05	0.000492	CcSEcCtD
Bicalutamide—Rash—Glimepiride—type 2 diabetes mellitus	7.51e-05	0.00049	CcSEcCtD
Bicalutamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.51e-05	0.000489	CcSEcCtD
Bicalutamide—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000489	CcSEcCtD
Bicalutamide—Rash—Sitagliptin—type 2 diabetes mellitus	7.49e-05	0.000488	CcSEcCtD
Bicalutamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.48e-05	0.000488	CcSEcCtD
Bicalutamide—Headache—Glimepiride—type 2 diabetes mellitus	7.47e-05	0.000487	CcSEcCtD
Bicalutamide—Cough—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000486	CcSEcCtD
Bicalutamide—Headache—Sitagliptin—type 2 diabetes mellitus	7.44e-05	0.000485	CcSEcCtD
Bicalutamide—Anaemia—Losartan—type 2 diabetes mellitus	7.43e-05	0.000484	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000481	CcSEcCtD
Bicalutamide—Oedema—Metformin—type 2 diabetes mellitus	7.38e-05	0.000481	CcSEcCtD
Bicalutamide—Hypertension—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.00048	CcSEcCtD
Bicalutamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.36e-05	0.000479	CcSEcCtD
Bicalutamide—Angioedema—Losartan—type 2 diabetes mellitus	7.34e-05	0.000478	CcSEcCtD
Bicalutamide—Infection—Metformin—type 2 diabetes mellitus	7.33e-05	0.000478	CcSEcCtD
Bicalutamide—Insomnia—Valsartan—type 2 diabetes mellitus	7.33e-05	0.000478	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.3e-05	0.000476	CcSEcCtD
Bicalutamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.28e-05	0.000474	CcSEcCtD
Bicalutamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000474	CcSEcCtD
Bicalutamide—Chest pain—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000474	CcSEcCtD
Bicalutamide—Myalgia—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000474	CcSEcCtD
Bicalutamide—Shock—Metformin—type 2 diabetes mellitus	7.26e-05	0.000473	CcSEcCtD
Bicalutamide—Insomnia—Orlistat—type 2 diabetes mellitus	7.25e-05	0.000472	CcSEcCtD
Bicalutamide—Anxiety—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000472	CcSEcCtD
Bicalutamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.24e-05	0.000472	CcSEcCtD
Bicalutamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.24e-05	0.000472	CcSEcCtD
Bicalutamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.23e-05	0.000471	CcSEcCtD
Bicalutamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000471	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.00047	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.22e-05	0.00047	CcSEcCtD
Bicalutamide—Somnolence—Valsartan—type 2 diabetes mellitus	7.21e-05	0.00047	CcSEcCtD
Bicalutamide—Syncope—Losartan—type 2 diabetes mellitus	7.2e-05	0.00047	CcSEcCtD
Bicalutamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000469	CcSEcCtD
Bicalutamide—Skin disorder—Metformin—type 2 diabetes mellitus	7.17e-05	0.000467	CcSEcCtD
Bicalutamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000466	CcSEcCtD
Bicalutamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.14e-05	0.000465	CcSEcCtD
Bicalutamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.14e-05	0.000465	CcSEcCtD
Bicalutamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000465	CcSEcCtD
Bicalutamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.11e-05	0.000463	CcSEcCtD
Bicalutamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000463	CcSEcCtD
Bicalutamide—Nausea—Glimepiride—type 2 diabetes mellitus	7.08e-05	0.000461	CcSEcCtD
Bicalutamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000461	CcSEcCtD
Bicalutamide—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.06e-05	0.00046	CcSEcCtD
Bicalutamide—Nausea—Sitagliptin—type 2 diabetes mellitus	7.06e-05	0.00046	CcSEcCtD
Bicalutamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.05e-05	0.00046	CcSEcCtD
Bicalutamide—Asthenia—Glyburide—type 2 diabetes mellitus	7.05e-05	0.00046	CcSEcCtD
Bicalutamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000459	CcSEcCtD
Bicalutamide—Anorexia—Metformin—type 2 diabetes mellitus	7.04e-05	0.000459	CcSEcCtD
Bicalutamide—Cough—Losartan—type 2 diabetes mellitus	7.01e-05	0.000457	CcSEcCtD
Bicalutamide—Urticaria—Gliclazide—type 2 diabetes mellitus	7.01e-05	0.000457	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7e-05	0.000456	CcSEcCtD
Bicalutamide—Alopecia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000456	CcSEcCtD
Bicalutamide—Fatigue—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000456	CcSEcCtD
Bicalutamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000455	CcSEcCtD
Bicalutamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000455	CcSEcCtD
Bicalutamide—Oedema—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000454	CcSEcCtD
Bicalutamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.96e-05	0.000454	CcSEcCtD
Bicalutamide—Pruritus—Glyburide—type 2 diabetes mellitus	6.95e-05	0.000453	CcSEcCtD
Bicalutamide—Mental disorder—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000452	CcSEcCtD
Bicalutamide—Constipation—Valsartan—type 2 diabetes mellitus	6.93e-05	0.000452	CcSEcCtD
Bicalutamide—Infection—Irbesartan—type 2 diabetes mellitus	6.92e-05	0.000451	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.92e-05	0.000451	CcSEcCtD
Bicalutamide—Fatigue—Orlistat—type 2 diabetes mellitus	6.91e-05	0.00045	CcSEcCtD
Bicalutamide—Malnutrition—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000449	CcSEcCtD
Bicalutamide—Shock—Irbesartan—type 2 diabetes mellitus	6.85e-05	0.000447	CcSEcCtD
Bicalutamide—Pain—Orlistat—type 2 diabetes mellitus	6.85e-05	0.000446	CcSEcCtD
Bicalutamide—Chest pain—Losartan—type 2 diabetes mellitus	6.84e-05	0.000446	CcSEcCtD
Bicalutamide—Myalgia—Losartan—type 2 diabetes mellitus	6.84e-05	0.000446	CcSEcCtD
Bicalutamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.84e-05	0.000445	CcSEcCtD
Bicalutamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000445	CcSEcCtD
Bicalutamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.82e-05	0.000445	CcSEcCtD
Bicalutamide—Anxiety—Losartan—type 2 diabetes mellitus	6.82e-05	0.000444	CcSEcCtD
Bicalutamide—Rash—Bromocriptine—type 2 diabetes mellitus	6.78e-05	0.000442	CcSEcCtD
Bicalutamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.77e-05	0.000441	CcSEcCtD
Bicalutamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000441	CcSEcCtD
Bicalutamide—Tension—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000441	CcSEcCtD
Bicalutamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000439	CcSEcCtD
Bicalutamide—Headache—Bromocriptine—type 2 diabetes mellitus	6.73e-05	0.000439	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.73e-05	0.000438	CcSEcCtD
Bicalutamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.72e-05	0.000438	CcSEcCtD
Bicalutamide—Nervousness—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000436	CcSEcCtD
Bicalutamide—Dry mouth—Losartan—type 2 diabetes mellitus	6.69e-05	0.000436	CcSEcCtD
Bicalutamide—Anorexia—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000433	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.63e-05	0.000432	CcSEcCtD
Bicalutamide—Paraesthesia—Metformin—type 2 diabetes mellitus	6.63e-05	0.000432	CcSEcCtD
Bicalutamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000432	CcSEcCtD
Bicalutamide—Confusional state—Losartan—type 2 diabetes mellitus	6.61e-05	0.000431	CcSEcCtD
Bicalutamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.6e-05	0.00043	CcSEcCtD
Bicalutamide—Dyspnoea—Metformin—type 2 diabetes mellitus	6.58e-05	0.000429	CcSEcCtD
Bicalutamide—Somnolence—Metformin—type 2 diabetes mellitus	6.56e-05	0.000428	CcSEcCtD
Bicalutamide—Oedema—Losartan—type 2 diabetes mellitus	6.56e-05	0.000427	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.55e-05	0.000427	CcSEcCtD
Bicalutamide—Infection—Losartan—type 2 diabetes mellitus	6.51e-05	0.000425	CcSEcCtD
Bicalutamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.5e-05	0.000424	CcSEcCtD
Bicalutamide—Dyspepsia—Metformin—type 2 diabetes mellitus	6.5e-05	0.000424	CcSEcCtD
Bicalutamide—Shock—Losartan—type 2 diabetes mellitus	6.45e-05	0.00042	CcSEcCtD
Bicalutamide—Urticaria—Valsartan—type 2 diabetes mellitus	6.44e-05	0.00042	CcSEcCtD
Bicalutamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.43e-05	0.000419	CcSEcCtD
Bicalutamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.42e-05	0.000418	CcSEcCtD
Bicalutamide—Decreased appetite—Metformin—type 2 diabetes mellitus	6.42e-05	0.000418	CcSEcCtD
Bicalutamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.41e-05	0.000418	CcSEcCtD
Bicalutamide—Nausea—Bromocriptine—type 2 diabetes mellitus	6.39e-05	0.000416	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.37e-05	0.000415	CcSEcCtD
Bicalutamide—Fatigue—Metformin—type 2 diabetes mellitus	6.37e-05	0.000415	CcSEcCtD
Bicalutamide—Urticaria—Orlistat—type 2 diabetes mellitus	6.36e-05	0.000415	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000414	CcSEcCtD
Bicalutamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.34e-05	0.000413	CcSEcCtD
Bicalutamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.33e-05	0.000413	CcSEcCtD
Bicalutamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.33e-05	0.000413	CcSEcCtD
Bicalutamide—Asthenia—Gliclazide—type 2 diabetes mellitus	6.33e-05	0.000413	CcSEcCtD
Bicalutamide—Constipation—Metformin—type 2 diabetes mellitus	6.31e-05	0.000411	CcSEcCtD
Bicalutamide—Angioedema—Ramipril—type 2 diabetes mellitus	6.29e-05	0.00041	CcSEcCtD
Bicalutamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.26e-05	0.000408	CcSEcCtD
Bicalutamide—Anorexia—Losartan—type 2 diabetes mellitus	6.25e-05	0.000407	CcSEcCtD
Bicalutamide—Vomiting—Glyburide—type 2 diabetes mellitus	6.25e-05	0.000407	CcSEcCtD
Bicalutamide—Pruritus—Gliclazide—type 2 diabetes mellitus	6.24e-05	0.000407	CcSEcCtD
Bicalutamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000405	CcSEcCtD
Bicalutamide—Rash—Glyburide—type 2 diabetes mellitus	6.2e-05	0.000404	CcSEcCtD
Bicalutamide—Somnolence—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000404	CcSEcCtD
Bicalutamide—Dermatitis—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000403	CcSEcCtD
Bicalutamide—Syncope—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000403	CcSEcCtD
Bicalutamide—Headache—Glyburide—type 2 diabetes mellitus	6.16e-05	0.000401	CcSEcCtD
Bicalutamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.0004	CcSEcCtD
Bicalutamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.08e-05	0.000397	CcSEcCtD
Bicalutamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000395	CcSEcCtD
Bicalutamide—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000395	CcSEcCtD
Bicalutamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.04e-05	0.000393	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.04e-05	0.000393	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000392	CcSEcCtD
Bicalutamide—Cough—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000392	CcSEcCtD
Bicalutamide—Fatigue—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000391	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.97e-05	0.000389	CcSEcCtD
Bicalutamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000389	CcSEcCtD
Bicalutamide—Constipation—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000388	CcSEcCtD
Bicalutamide—Pain—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000388	CcSEcCtD
Bicalutamide—Insomnia—Losartan—type 2 diabetes mellitus	5.93e-05	0.000387	CcSEcCtD
Bicalutamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.9e-05	0.000385	CcSEcCtD
Bicalutamide—Paraesthesia—Losartan—type 2 diabetes mellitus	5.89e-05	0.000384	CcSEcCtD
Bicalutamide—Urticaria—Metformin—type 2 diabetes mellitus	5.87e-05	0.000382	CcSEcCtD
Bicalutamide—Chest pain—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000382	CcSEcCtD
Bicalutamide—Myalgia—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000382	CcSEcCtD
Bicalutamide—Dyspnoea—Losartan—type 2 diabetes mellitus	5.85e-05	0.000381	CcSEcCtD
Bicalutamide—Anxiety—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000381	CcSEcCtD
Bicalutamide—Nausea—Glyburide—type 2 diabetes mellitus	5.84e-05	0.00038	CcSEcCtD
Bicalutamide—Abdominal pain—Metformin—type 2 diabetes mellitus	5.84e-05	0.00038	CcSEcCtD
Bicalutamide—Dizziness—Gliclazide—type 2 diabetes mellitus	5.84e-05	0.00038	CcSEcCtD
Bicalutamide—Somnolence—Losartan—type 2 diabetes mellitus	5.83e-05	0.00038	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.82e-05	0.00038	CcSEcCtD
Bicalutamide—Asthenia—Valsartan—type 2 diabetes mellitus	5.82e-05	0.000379	CcSEcCtD
Bicalutamide—Dyspepsia—Losartan—type 2 diabetes mellitus	5.77e-05	0.000376	CcSEcCtD
Bicalutamide—Asthenia—Orlistat—type 2 diabetes mellitus	5.75e-05	0.000375	CcSEcCtD
Bicalutamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000374	CcSEcCtD
Bicalutamide—Pruritus—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000374	CcSEcCtD
Bicalutamide—Dry mouth—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000374	CcSEcCtD
Bicalutamide—Decreased appetite—Losartan—type 2 diabetes mellitus	5.7e-05	0.000371	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000371	CcSEcCtD
Bicalutamide—Confusional state—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000369	CcSEcCtD
Bicalutamide—Pruritus—Orlistat—type 2 diabetes mellitus	5.67e-05	0.000369	CcSEcCtD
Bicalutamide—Fatigue—Losartan—type 2 diabetes mellitus	5.65e-05	0.000368	CcSEcCtD
Bicalutamide—Oedema—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000366	CcSEcCtD
Bicalutamide—Vomiting—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000366	CcSEcCtD
Bicalutamide—Constipation—Losartan—type 2 diabetes mellitus	5.61e-05	0.000365	CcSEcCtD
Bicalutamide—Pain—Losartan—type 2 diabetes mellitus	5.61e-05	0.000365	CcSEcCtD
Bicalutamide—Rash—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000363	CcSEcCtD
Bicalutamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000362	CcSEcCtD
Bicalutamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000362	CcSEcCtD
Bicalutamide—Urticaria—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000361	CcSEcCtD
Bicalutamide—Shock—Ramipril—type 2 diabetes mellitus	5.53e-05	0.00036	CcSEcCtD
Bicalutamide—Headache—Gliclazide—type 2 diabetes mellitus	5.53e-05	0.00036	CcSEcCtD
Bicalutamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000359	CcSEcCtD
Bicalutamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000359	CcSEcCtD
Bicalutamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000359	CcSEcCtD
Bicalutamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000359	CcSEcCtD
Bicalutamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.48e-05	0.000357	CcSEcCtD
Bicalutamide—Skin disorder—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000356	CcSEcCtD
Bicalutamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000354	CcSEcCtD
Bicalutamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.4e-05	0.000352	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.36e-05	0.000349	CcSEcCtD
Bicalutamide—Dizziness—Valsartan—type 2 diabetes mellitus	5.36e-05	0.000349	CcSEcCtD
Bicalutamide—Anorexia—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000349	CcSEcCtD
Bicalutamide—Dizziness—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000345	CcSEcCtD
Bicalutamide—Asthenia—Metformin—type 2 diabetes mellitus	5.3e-05	0.000345	CcSEcCtD
Bicalutamide—Nausea—Gliclazide—type 2 diabetes mellitus	5.24e-05	0.000342	CcSEcCtD
Bicalutamide—Pruritus—Metformin—type 2 diabetes mellitus	5.22e-05	0.00034	CcSEcCtD
Bicalutamide—Urticaria—Losartan—type 2 diabetes mellitus	5.21e-05	0.000339	CcSEcCtD
Bicalutamide—Body temperature increased—Losartan—type 2 diabetes mellitus	5.18e-05	0.000338	CcSEcCtD
Bicalutamide—Abdominal pain—Losartan—type 2 diabetes mellitus	5.18e-05	0.000338	CcSEcCtD
Bicalutamide—Vomiting—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000336	CcSEcCtD
Bicalutamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000335	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000334	CcSEcCtD
Bicalutamide—Rash—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000333	CcSEcCtD
Bicalutamide—Dermatitis—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000333	CcSEcCtD
Bicalutamide—Vomiting—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000332	CcSEcCtD
Bicalutamide—Insomnia—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000331	CcSEcCtD
Bicalutamide—Headache—Valsartan—type 2 diabetes mellitus	5.08e-05	0.000331	CcSEcCtD
Bicalutamide—Diarrhoea—Metformin—type 2 diabetes mellitus	5.05e-05	0.000329	CcSEcCtD
Bicalutamide—Rash—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000329	CcSEcCtD
Bicalutamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000329	CcSEcCtD
Bicalutamide—Dermatitis—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000329	CcSEcCtD
Bicalutamide—Headache—Orlistat—type 2 diabetes mellitus	5.02e-05	0.000327	CcSEcCtD
Bicalutamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000327	CcSEcCtD
Bicalutamide—Asthenia—Irbesartan—type 2 diabetes mellitus	5e-05	0.000326	CcSEcCtD
Bicalutamide—Somnolence—Ramipril—type 2 diabetes mellitus	5e-05	0.000326	CcSEcCtD
Bicalutamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000323	CcSEcCtD
Bicalutamide—Pruritus—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000321	CcSEcCtD
Bicalutamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000319	CcSEcCtD
Bicalutamide—Dizziness—Metformin—type 2 diabetes mellitus	4.88e-05	0.000318	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000316	CcSEcCtD
Bicalutamide—Fatigue—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000316	CcSEcCtD
Bicalutamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.83e-05	0.000315	CcSEcCtD
Bicalutamide—Nausea—Valsartan—type 2 diabetes mellitus	4.82e-05	0.000314	CcSEcCtD
Bicalutamide—Constipation—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000313	CcSEcCtD
Bicalutamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000311	CcSEcCtD
Bicalutamide—Nausea—Orlistat—type 2 diabetes mellitus	4.76e-05	0.00031	CcSEcCtD
Bicalutamide—Asthenia—Losartan—type 2 diabetes mellitus	4.7e-05	0.000307	CcSEcCtD
Bicalutamide—Vomiting—Metformin—type 2 diabetes mellitus	4.69e-05	0.000306	CcSEcCtD
Bicalutamide—Rash—Metformin—type 2 diabetes mellitus	4.66e-05	0.000303	CcSEcCtD
Bicalutamide—Dermatitis—Metformin—type 2 diabetes mellitus	4.65e-05	0.000303	CcSEcCtD
Bicalutamide—Pruritus—Losartan—type 2 diabetes mellitus	4.64e-05	0.000302	CcSEcCtD
Bicalutamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000302	CcSEcCtD
Bicalutamide—Headache—Metformin—type 2 diabetes mellitus	4.63e-05	0.000301	CcSEcCtD
Bicalutamide—Dizziness—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.0003	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.6e-05	0.0003	CcSEcCtD
Bicalutamide—Diarrhoea—Losartan—type 2 diabetes mellitus	4.49e-05	0.000292	CcSEcCtD
Bicalutamide—Urticaria—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000291	CcSEcCtD
Bicalutamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.44e-05	0.00029	CcSEcCtD
Bicalutamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.44e-05	0.00029	CcSEcCtD
Bicalutamide—Vomiting—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000289	CcSEcCtD
Bicalutamide—Rash—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000286	CcSEcCtD
Bicalutamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000286	CcSEcCtD
Bicalutamide—Nausea—Metformin—type 2 diabetes mellitus	4.39e-05	0.000286	CcSEcCtD
Bicalutamide—Headache—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000284	CcSEcCtD
Bicalutamide—Dizziness—Losartan—type 2 diabetes mellitus	4.34e-05	0.000283	CcSEcCtD
Bicalutamide—Vomiting—Losartan—type 2 diabetes mellitus	4.17e-05	0.000272	CcSEcCtD
Bicalutamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Bicalutamide—Nausea—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.00027	CcSEcCtD
Bicalutamide—Rash—Losartan—type 2 diabetes mellitus	4.13e-05	0.000269	CcSEcCtD
Bicalutamide—Dermatitis—Losartan—type 2 diabetes mellitus	4.13e-05	0.000269	CcSEcCtD
Bicalutamide—Headache—Losartan—type 2 diabetes mellitus	4.11e-05	0.000268	CcSEcCtD
Bicalutamide—Asthenia—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000263	CcSEcCtD
Bicalutamide—Pruritus—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000259	CcSEcCtD
Bicalutamide—Nausea—Losartan—type 2 diabetes mellitus	3.89e-05	0.000254	CcSEcCtD
Bicalutamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000251	CcSEcCtD
Bicalutamide—Dizziness—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000242	CcSEcCtD
Bicalutamide—Vomiting—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000233	CcSEcCtD
Bicalutamide—Rash—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000231	CcSEcCtD
Bicalutamide—Dermatitis—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000231	CcSEcCtD
Bicalutamide—Headache—Ramipril—type 2 diabetes mellitus	3.52e-05	0.00023	CcSEcCtD
Bicalutamide—Nausea—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000218	CcSEcCtD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.93e-06	0.000238	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SERPINE1—type 2 diabetes mellitus	8.84e-06	0.000236	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.71e-06	0.000233	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.7e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.7e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.65e-06	0.000231	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	8.63e-06	0.00023	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	8.57e-06	0.000229	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	8.5e-06	0.000227	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.49e-06	0.000227	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.4e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.4e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.4e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.4e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.4e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.38e-06	0.000224	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	8.28e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	8.28e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	8.28e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	8.28e-06	0.000221	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.21e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	8.21e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	8.21e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	8.21e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	8.21e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	8.13e-06	0.000217	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.12e-06	0.000217	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	8.02e-06	0.000214	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	7.94e-06	0.000212	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.89e-06	0.000211	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7.87e-06	0.00021	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.68e-06	0.000205	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.68e-06	0.000205	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.64e-06	0.000204	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	7.49e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.49e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.48e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.4e-06	0.000198	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	7.38e-06	0.000197	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	7.34e-06	0.000196	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	7.34e-06	0.000196	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	7.31e-06	0.000195	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	7.19e-06	0.000192	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.15e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	7.15e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	7.15e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	7.15e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.14e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.14e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.14e-06	0.000191	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	7.1e-06	0.00019	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	6.98e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	6.9e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	6.89e-06	0.000184	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.85e-06	0.000183	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.85e-06	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.83e-06	0.000182	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.75e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.75e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.69e-06	0.000179	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.69e-06	0.000179	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.62e-06	0.000177	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.59e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.59e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.58e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.58e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.58e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.56e-06	0.000175	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.53e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.52e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.52e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.52e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.52e-06	0.000174	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.48e-06	0.000173	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.47e-06	0.000173	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.43e-06	0.000172	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.42e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.41e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.41e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.41e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.36e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.36e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.36e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.36e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.34e-06	0.000169	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.29e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.29e-06	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.24e-06	0.000167	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.15e-06	0.000164	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.1e-06	0.000163	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.98e-06	0.00016	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.9e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.9e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.9e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.86e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.86e-06	0.000157	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.85e-06	0.000156	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.85e-06	0.000156	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.85e-06	0.000156	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.8e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.8e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.79e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.74e-06	0.000153	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.74e-06	0.000153	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.69e-06	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5.66e-06	0.000151	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.63e-06	0.00015	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.61e-06	0.00015	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.61e-06	0.00015	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.6e-06	0.00015	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.57e-06	0.000149	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.56e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.56e-06	0.000148	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.41e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.41e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.41e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.41e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.39e-06	0.000144	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.35e-06	0.000143	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.33e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.33e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.29e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.29e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.2e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.19e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.16e-06	0.000138	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.13e-06	0.000137	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.11e-06	0.000137	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.11e-06	0.000137	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.07e-06	0.000135	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.07e-06	0.000135	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.82e-06	0.000129	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.79e-06	0.000128	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.79e-06	0.000128	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.77e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.71e-06	0.000126	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.57e-06	0.000122	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.5e-06	0.00012	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.44e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.41e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.41e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.41e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.41e-06	0.000118	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.39e-06	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.37e-06	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.37e-06	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.36e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.35e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.33e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.33e-06	0.000116	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.3e-06	0.000115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.3e-06	0.000115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.3e-06	0.000115	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.29e-06	0.000115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.27e-06	0.000114	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.27e-06	0.000114	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.26e-06	0.000114	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.2e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.2e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.17e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.15e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.15e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.09e-06	0.000109	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.09e-06	0.000109	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.05e-06	0.000108	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.01e-06	0.000107	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.98e-06	0.000106	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.93e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.93e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.91e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.89e-06	0.000104	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.88e-06	0.000104	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—type 2 diabetes mellitus	3.88e-06	0.000104	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.86e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.86e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.86e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.85e-06	0.000103	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.81e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.78e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.78e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.76e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.75e-06	0.0001	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.73e-06	9.96e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.73e-06	9.96e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.67e-06	9.8e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.67e-06	9.8e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.66e-06	9.76e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.61e-06	9.65e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.61e-06	9.65e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.58e-06	9.56e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.54e-06	9.46e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.53e-06	9.42e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.51e-06	9.38e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.49e-06	9.31e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.49e-06	9.31e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.43e-06	9.16e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.4e-06	9.09e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.38e-06	9.01e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.36e-06	8.98e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.35e-06	8.93e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.34e-06	8.93e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.34e-06	8.93e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.33e-06	8.9e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.32e-06	8.88e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.3e-06	8.8e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	8.5e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.12e-06	8.34e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.93e-06	7.82e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.9e-06	7.75e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.88e-06	7.69e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.88e-06	7.69e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.87e-06	7.67e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.87e-06	7.66e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.86e-06	7.65e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.85e-06	7.61e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.83e-06	7.56e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.75e-06	7.34e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	7.31e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	7.31e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.67e-06	7.14e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.63e-06	7.03e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.62e-06	7e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.61e-06	6.97e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.57e-06	6.86e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.56e-06	6.83e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	6.73e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	6.73e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	6.69e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.5e-06	6.67e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.5e-06	6.67e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.49e-06	6.66e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.46e-06	6.57e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.36e-06	6.31e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.32e-06	6.19e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.3e-06	6.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.28e-06	6.1e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.24e-06	5.99e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.21e-06	5.89e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.2e-06	5.87e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.17e-06	5.8e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.92e-06	5.11e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.88e-06	5.02e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.72e-06	4.6e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.65e-06	4.4e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.65e-06	4.4e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-06	4.02e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	3.36e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	3.09e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.15e-06	3.07e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.57e-07	2.02e-05	CbGpPWpGaD
